Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-15-045748
Filing Date
2015-06-16
Accepted
2015-06-16 18:32:26
Documents
1
Period of Report
2015-06-12

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3822
  Complete submission text file 0001104659-15-045748.txt   5192
Mailing Address C/O KARYOPHARM THERAPEUTICS INC. 85 WELLS AVENUE, SECOND FLOOR NEWTON MA 02459
Business Address
Kauffman Michael (Reporting) CIK: 0001364719 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35403 | Film No.: 15935391

Mailing Address 215 FIRST STREET SUITE 440 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 440 CAMBRIDGE MA 02142 617-252-9300
Verastem, Inc. (Issuer) CIK: 0001526119 (see all company filings)

EIN.: 273269467 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations